Among the different approaches to insulin therapy, the continuous-rate infusion (CRI) of regular insulin has gained widespread use due to its ability to provide stable plasma insulin concentrations and facilitate a gradual reduction in blood glucose levels without triggering hypoglycemia [5]. This evidence concerns the gene INS and Hypoglycemia.